ArticleCancer immunology, immunotherapy : CII2024

Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models.

Hongyu Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.